Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

New research shows patients can skip the dreaded colonoscopy without sacrificing protection from colorectal cancer.

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

Experts point to a combination of environmental factors and lifestyle factors, such as diets high in red meat and ...

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...